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ABSTRACT
Objective: Nigella sativa and its active constituent thymoquinone (TQ) have been extensively documented for its pharmacological values, but its 
application in wound healing in particular in a diabetic wound healing model is less documented.
Methods: In our study, alloxan-induced diabetic rats were used as a chronic delayed wound model and topical administration of TQ 10% w/v were 
used to assess the role and function of TQ in wound healing through wound contraction and histological analysis.
Results: Although statistically insignificant, we found out that TQ accelerated wound healing in post-wounding day 3 (inflammatory phase), whereas 
aggressively decelerating wound healing in post-wounding day 7 (proliferation phase). In addition, our histological analyses of wound granulation 
tissues at post-wounding day 14 substantiate our claim by showing that TQ treatment had delayed wound healing progression of the diabetic rats.
Conclusions: Our study shows that TQ accelerates wound healing during the inflammatory phase; however, decelerate rapidly during the proliferation 
phase. We speculate the acceleration of wound healing during the inflammatory phase was due to its well-documented antioxidant, anti-inflammatory, 
and antimicrobial properties while its deceleration of wound healing during the proliferation phase was due to its well-documented antiangiogenic effect.
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INTRODUCTION
Naturally, cutaneous wound heals spontaneously and does not 
necessitate any medical aid [1]. It is a continual, overlapping but 
independent event occurring in four described phases mainly 
hemostasis, inflammation, proliferation (early granulation), and 
remodeling (late granulation) with their own standard time frame.
Chronic non-healing ulceration is commonly associated with 
diabetes mellitus affecting approximately 2-4% of patients [2-4]. 
Ulceration is as a result of collective tissue breakdown manifested by 
impaired healing [4,5]. This is primarily associated with a series of 
macrovascular and microvascular alteration that leads to many systemic 
complications [4,6]. These systemic complications will result in delayed 
wound healing that may eventually lead to limb amputation [4,7]. Non-
traumatic lower limb amputation is one of the worst complications 
of diabetes. Treatment is naturally difficult due to predominance of 
polymicrobial with multidrug resistance and capability of biofilm 
formation [8].
Most modern medicines today are derived from the study of medicinal 
plants. Plants have been phytochemically screened and tested for the 
past 210 years [9]. It is appealing to consider effective phytochemicals 
such as to treat against bacterial infection and at the same time, improve 
inflammatory and angiogenic functions in wound healing.
Thymoquinone (TQ) (2-methyl-5-isopropyl-1,4-benzoquinone) was 
first phytochemically screened and isolated by El-Dakhakhny [10]. 
As of yet, in vivo model has yet been employed to evaluate wound 
healing ability of Nigella sativa and its active constituent TQ. The 
nearest preclinical trial of such was using a scratch assay of fibroblast 
migration using N. sativa seed extract described recently by Ab Rahman 
et al. [11] TQ strong antioxidant-associated capacities and strong 
antimicrobial property, all suggested that TQ is a desirable wound 
healing alternative [12]. Due to TQ high pharmacological value and the 
severity of chronic non-healing complication, it is imperative to explore 
the medicinal activity of TQ in wound healing therapy. Hence, our 
present study was conducted to investigate to determine the effect of 
TQ in the wound healing progression of alloxan-induced diabetic rats.
METHODS
Animal
Male Wistar rats aged 10-12 weeks were used in all experiments. 
Approval for work and procedures with animals has been granted by 
the UBD University Research Ethics Committee. Rats were kept under 
optimal controlled humidity on a 12 hrs light/dark circle. Feeding 
pellets and sufficient access to clean water were provided.
Diabetes induction
Animals were fasted overnight with access to water ad libitum. Alloxan 
monohydrate (Sigma Chemicals, USA) was freshly dissolved in 0.9% 
saline solution (w/v). Animals were administered with a single dose of 
alloxan administration at 120 mg/kg through the intraperitoneal route.
Blood glucose levels were measured at 36 hrs and 72 hrs after alloxan 
administration to confirm hyperglycemia and before the experimental 
conduct. During the course of the experiment, blood glucose levels 
and body weight of rats were recorded at day 0, day 7, and day 14 to 
ensure successful diabetes induction. Blood glucose parameter was 
as previously described [13], rats with blood glucose readings of 
≥300 mg/dL were used for the study.
Wound excision
Rats were anesthetized using ether fume inhalation method as 
previously described [14]. Excisional wounds were made as previously 
described with slight modifications [15]. Dorsal skin was shaved 
using electric razor and cleaned using repeated application of 
ethanol. An excision full thickness of approximately 5 mm was made 
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surgical equipment. Wounds were cleaned with repeated flushing 
of 0.9% w/v saline solution and dried with cleaned gauze. The first 
topical application was then administered to the wound with their 
own assigned treatments. Wounds were left exposed uncovered and 
monitored daily.
Groupings and treatments
Diabetic rats were grouped into two groups at 5 animals per group. 
Control vehicle only group was administered topically with white 
petroleum jelly (Vaseline® Jelly) while treated group was administered 
topically with 10% of TQ (TQ powder; Sigma Chemicals, USA) in 
petroleum  jelly  (w/v).  TQ  was  administered  on  alternate  days  for 
14 days.
Wound contraction
Photographs of wounds of all the rats were taken and respective wound 
area  measurements  were  determined  using  Image  J  1.48v  software 
(National Institute Health, USA). The percentage of wound contractions 
were  calculated  using  formula  as  previously  described  [15]:  Rate  of 
wound contraction = [(original wound area-open area on final day)/
original wound area] ×100%.
Histological observation
At post-wounding day 14, animals were euthanized using carbon 
dioxide asphyxiation, and the wound granulated tissue was harvested 
and fixed in 3.7% neutral buffered formaldehyde for at least 36 hrs for 
histological analysis. Tissues were then processed and embedded in 
paraffin wax. Serial sections of 10 μm thick were cut and stained with 
hemotoxylin for histological investigation. Images were visualized and 
captured under digital microscope Olympus ix73 with the aid of cellsens 
software. Observation was in accordance to relative expectation of size, 
shape, and color of cells in hemotoxylin and eosin staining [16].
Statistical analysis
Statistical significance was determined using one-way ANOVA, followed 
by Tukey’s HSD post hoc test. Data were represented as the mean ± SEM, 
and the difference was considered significant at p<0.05.
RESULTS
Effect of blood glucose and body weight in alloxan treatment
Alloxan-induced rats which were confirmed hyperglycemic were used 
in the experiment. From day 0 of experimental study, rats showed 
that there were no significant trends in their blood glucose levels and 
body weight measurements at weekly intervals (Table 1). The rats 
demonstrated no fluctuations in blood glucose levels and body weights 
during the course of the experiment.
Gross observation of wound contraction
Macroscopic evaluation of wound healing progression in Fig. 1a 
characterized the early formation and shedding of scabs as well as 
the size of the wound site through wound contraction measurement. 
As wound healing progress, there are noticeable differences at post-
wounding day 7 and 14 between the experimental groups. Evidently, 
TQ is shown to decelerate wound healing after 7 days of treatment and 
is further decelerated at post-wounding day 14. Although insignificant, 
average percentage of wound contraction in Fig. 1b supports the wound 
healing deceleration in TQ treatment. In addition, there is noticeable 
increase in wound contraction at post-wounding day 3 in effect of TQ 
treatment.
Histological observation of wound granulation at post-wounding 
day 14
Delayed wound healing model as expected in diabetes-induced rats, 
both groups have shown unorganized collagen depositions (Fig. 2). In 
addition, hematoxylin staining shows visible well-developed capillary 
systems in both experimental groups. Furthermore, both groups show 
the infiltration of inflammatory cells and fibroblasts. This indicates 
both are in the active proliferation phase.
However, there are noticeable morphological differences in cell 
infiltration levels, suggesting they are not in the same timeline phase 
with one another (Fig. 2). In the control group, histological assessment 
shows relatively low infiltration of inflammatory cells in comparison 
to TQ-treated group. The reduction of inflammatory cells in control 
group indicates wound healing is faster than the wound healing in TQ-
treated group. Furthermore, high infiltration of fibroblast in control 
group shows that wound healing is actively progressing, exiting the 
proliferation phase. Low infiltration of  fibroblast  in TQ-treated group 
indicates the beginning timeline of fibroblast recruitment, thus a little 
behind from exiting the proliferation phase.
DISCUSSION
Our study primarily focuses on the effect of TQ in treating delayed 
chronic wound healing as a result of metabolic impairment of 
diabetes. Our results have shown possible selective effect posed on 
different wound healing cascades. Wound healing is a dynamic and 
complex system; thus, repair processes are in stages but overlapping 
cascades [17]. During these cascade events, wound permeation differs 
Table 1: Average blood glucose levels and body weights
Group Blood glucose (mg/dL) Body weight (g)
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
Control 512±45 495±43 539±34 207±9 207±9 207±9
TQ 513±46 516±50 518±34 184±10 184±10 184±10
Data are presented as mean±SEM (n=5 per group)
Fig. 2: Histological section of wound granulation tissues of 
control and TQ-treated groups on post-wounding day 14 
(arrows: BV: Blood vessel; F: Fibroblast, IC: Inflammatory cell)
Fig. 1: (a) Wound healing progression in diabetic models with 
vehicle (control) and TQ treatments at given post-wounding time 
points, (b) average percentage of wound contractions at post-
wounding day 3, 7, and 14; data are presented as mean ± SEM 
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greatly due to physiological changes and transition from one phase 
to another. For instance, the behavior of drug for vasculature uptake 
is higher in a vasodilated environment compare to vasoconstricted 
environment [18].
Our result shows that for the early wound healing cascades, TQ 
has been effective in accelerating wound healing. During this early 
phase, an initial acute inflammatory response is onset to combat 
harmful stimuli [19]. This usually lasted for 3 days, and is simulated 
as our post-wounding day 3 in wound model. This acute inflammatory 
response is predominantly a non-specific immune response against 
infection and injury [20]. Neutrophils and macrophage infiltrations are 
important in the acute inflammatory phase of wound healing as these 
cells remove debris and kill bacteria through phagocytosis [21,22]. 
Moreover, this cascade is important to prepare the wound bed for 
subsequent recruitment and proliferation of cells; however, excessive 
inflammatory response will impair tissue granulation processes such 
as angiogenesis [17,23].
A study has shown that dysfunctional proinflammatory cellular 
function in hyperglycemic microenvironment hinders suboptimal 
interaction of reepithelialization process [24]. This shows that 
hyperglycemic metabolic impairment affects wound healing ability. 
Chronic wound healing in diabetic patients usually manifests badly 
in diabetic ulcer, and this occurs as a consequence of excess reactive 
oxygen species (ROS) and dysfunctional inflammatory function [21,25]. 
It is usually characterized by continual influx of neutrophils that release 
cytotoxic enzymes and inflammatory mediators that cause damage to 
surrounding tissue [26]. This response leads to a progressive shift in the 
type of cells present in the area of inflammation; thus, simultaneously 
destruct and heal tissue concurrently [19]. These, in turn, produce an 
imbalance of ROS status and lead to oxidative stress [26].
TQ has been documented as having antioxidant and anti-inflammatory 
effects effective for inflammatory diseases [20]. A study of metabolic 
impaired rats treated with curcumin, which also possessed antioxidant 
and anti-inflammatory effects show the acceleration of wound healing 
by relieving the excessive oxidative stress and minimize cytotoxic 
degradative environment in diabetic wound healing model [26]. In 
addition, improved wound morphology was observed from a different 
study, indicating a prominent role of the cell infiltrations and antioxidant 
activity [27]. TQ is also well known for its antimicrobial effect and thus 
effective in minimizing local inflammatory response and infection. 
A study of wound healing in burn model shows that these inflammatory 
and antimicrobial effects are responsible for accelerated wound healing 
capability of TQ [12]. However, more thorough investigation is needed 
to determine the role of TQ during the early phase of the wound healing 
(post-wounding day 3).
Alternatively, TQ is widely used and deemed effective in combating 
cancer and tumor, as opposed to the direction we want to achieve, for 
wound healing therapy. Early prognosis indicates that the disruption 
of angiogenic function in cancer cell is thought to be selective, affecting 
only the cancer cells, but not the normal cell [28,29]. This predicted 
selective effect of TQ was based on study showing toxicity in normal 
cells at the minimal level [30]. This is probably due to the quiescent 
nature of wound vascularization [29]. However, anticancer therapy 
using antiangiogenic medication shows interuption in wound healing 
processes as its cutaneous side effects [19].
Our study demonstrated a possible cutaneous effect from TQ treatment 
during the active angiogenesis process in our wound healing model 
at post-wounding days 7 and 14. During the early granulation phase, 
concurrent phases display the transitioning of wound healing event 
from inflammatory phase to proliferative phase indicated by the 
reduction of inflammatory cells. Myofibroblasts and microvessels 
are more predominant in wound healing, with peak at 7 days and 
progressively reduce overtime [31]. The granulation phase started when 
angiogenesis begin to occur, establishing a new vascular network [29]. 
This organization of vascular system provides necessary oxygen and 
nutrient supplements for wound healing repair [22]. Angiogenesis 
induction in endothelial cells is mediated by angiogenic factors such 
vascular endothelial  growth  factor  (VEGF)  [29]. These  factors  induce 
cell migration and proliferation of endothelial cells and thus direct 
capillary tube morphogenesis and vascular remodeling [29].
Inadequate angiogenesis independently leads to delay wound 
healing, and this is not so uncommon to people with diabetes [29,32]. 
Hyperglycemia induces pathological changes in endothelial function 
resulting to abnormal angiogenesis [33]. The local metabolic 
environment is impaired by diabetes manifesting macro- and micro-
vascular dysfunction that contributes to delayed wound healing [23]. 
The  inhibition  of  endothelial  response  to  injury  may  manifest 
occurrence of wound dehiscence, bleeding, and wound infection [29]. It 
is worth noting that impaired wound healing in diabetes is not only just 
characterized by a decrease in angiogenic function but also in reduction 
of endothelial progenitor cell recruitment [5]. Saito et al. had discovered 
that the subsets of endothelial progenitors are altered in diabetic rats, 
resulting in impaired endothelial vascular differentiation [34].
As angiogenesis function is disrupted, wound healing becomes 
chronically inflamed. Chronic inflammation hinders progression to 
subsequent granulation phase due to imbalance ROS and oxidative 
stress in wound [21]. This causes lipid peroxidation of organelles and 
cellular membranes, responsible to disrupt the function of fibroblast 
and endothelial cells [35]. In addition, lipid peroxidation is suspected 
to  impair  VEGF  expression  for  normal  angiogenesis  process  [35]. 
Antioxidant agents are effective to combat excessive ROS activity and 
thus minimize lipid peroxidation [22,25]. TQ has shown to improve 
endothelial function by reducing oxidative stress [36]. However, its 
antiangiogenic effect is probably stronger in decelerating wound 
healing.
To the best of our knowledge, the pathway of TQ in decelerating 
wound healing progression still remains unknown. Nevertheless, our 
histopathological analysis on post-wounding day 14 has indicated that 
wound healing is decelerated in TQ-treated group. However, more 
follow-up study is needed, and we suggest the utilization of oxidative 
stress and vascular motif to potentiate better investigation series.
CONCLUSION
Our data show that TQ accelerate wound healing in diabetic model 
during the inflammatory phase, this is possibly due to its well-known 
antioxidant, anti-inflammatory, and antimicrobial properties. However, 
TQ shifts its function, as wound healing is severely decelerated during 
granulation phase. We speculate the deceleration of wound healing is 
attributed due to TQ’s antiangiogenic property.
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